Multidrug-resistant Gram-negative Bacterial Bloodstream Infections in Children's Hospitals in Japan, 2010-2017

Yuta Aizawa1,2, Takayo Shoji3, Kenta Ito4

  • 1From the Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Insights

Multidrug-resistant Gram-negative bacilli bloodstream infections (MDR GNB BSI) in children are linked to cancer chemotherapy and older age. MDR GNB BSI did not significantly increase mortality rates in this pediatric study.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Microbiology
  • Hospital Epidemiology

Background:

  • Multidrug-resistant Gram-negative bacilli bloodstream infections (MDR GNB BSI) pose a significant threat in pediatric healthcare settings.
  • Risk factors and outcomes for MDR GNB BSI in children remain incompletely understood.
  • This study addresses the knowledge gap regarding pediatric MDR GNB BSI.

Purpose of the Study:

  • To identify risk factors associated with MDR GNB BSI in pediatric patients.
  • To evaluate the clinical outcomes of children experiencing MDR GNB BSI.
  • To compare MDR and non-MDR GNB BSI in a large cohort of children.

Main Methods:

  • Retrospective analysis of clinical and microbiological data from 629 GNB BSI episodes across 8 Japanese children's hospitals (April 2010-March 2017).
  • Comparison of risk factors and outcomes between multidrug-resistant (MDR) and non-multidrug-resistant (non-MDR) GNB BSI cases.
  • Statistical analysis to determine independent associations with MDR GNB BSI.

Main Results:

  • Multidrug-resistance (MDR) accounted for 24.5% of Gram-negative bacilli (GNB) bloodstream infections (BSI) in children, with no significant change over time.
  • Effective initial empiric therapy coverage was lower for MDR GNB BSI (60.4%) compared to non-MDR GNB BSI (83.4%).
  • Independent risk factors for MDR GNB BSI included recent cancer chemotherapy (OR 43.90), older age (OR 1.05), and neonatal ward admission (OR 0.019).

Conclusions:

  • Approximately one-fourth of pediatric GNB BSI cases were multidrug-resistant.
  • Cancer chemotherapy and older age are significant risk factors for developing MDR GNB BSI in pediatric hospitals.
  • MDR GNB BSI was not found to independently increase the 28-day all-cause mortality rate in this pediatric cohort.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...